Andras G. Lacko - Publications

Biochemistry and Molecular Biology University of North Texas Health Science Center at Fort Worth 
Biochemistry, Oncology

112 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Raut SG, Garud A, Nagarajan B, Sabnis N, Remaley A, Fudala R, Gryczynski I, Gryczynski Z, Dzyuba SV, Borejdo J, Lacko AG. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles, using Intrinsic Fluorescence. The Journal of Pharmacology and Experimental Therapeutics. PMID 31941718 DOI: 10.1124/jpet.119.262899  0.4
2019 Chen X, Mangala LS, Mooberry L, Bayraktar E, Dasari SK, Ma S, Ivan C, Court KA, Rodriguez-Aguayo C, Bayraktar R, Raut S, Sabnis N, Kong X, Yang X, Lopez-Berestein G, ... Lacko AG, et al. Identifying and targeting angiogenesis-related microRNAs in ovarian cancer. Oncogene. PMID 31289363 DOI: 10.1038/s41388-019-0862-y  0.36
2019 Berney E, Sabnis N, Panchoo M, Raut S, Dickerman R, Lacko AG. The SR-B1 Receptor as a Potential Target for Treating Glioblastoma. Journal of Oncology. 2019: 1805841. PMID 31275377 DOI: 10.1155/2019/1805841  0.4
2018 Isaac-Olivé K, Ocampo-García BE, Aranda-Lara L, Santos-Cuevas CL, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Medina LA, Nagarajan B, Sabnis N, Raut S, Prokai L, Lacko AG. [Tc-HYNIC-N-dodecylamide]: a new hydrophobic tracer for labelling reconstituted high-density lipoproteins (rHDL) for radioimaging. Nanoscale. PMID 30543234 DOI: 10.1039/c8nr07484d  0.4
2018 Raut S, Mooberry L, Sabnis N, Garud A, Dossou AS, Lacko A. Reconstituted HDL: Drug Delivery Platform for Overcoming Biological Barriers to Cancer Therapy. Frontiers in Pharmacology. 9: 1154. PMID 30374303 DOI: 10.3389/fphar.2018.01154  0.36
2018 Raut S, Dasseux JL, Sabnis NA, Mooberry L, Lacko A. Lipoproteins for therapeutic delivery: recent advances and future opportunities. Therapeutic Delivery. PMID 29495929 DOI: 10.4155/tde-2017-0122  0.4
2017 Sabnis S, Sabnis NA, Raut S, Lacko AG. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. International Journal of Nanomedicine. 12: 1453-1464. PMID 28260891 DOI: 10.2147/IJN.S122036  0.4
2016 Mooberry LK, Sabnis NA, Panchoo M, Nagarajan B, Lacko AG. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Frontiers in Pharmacology. 7: 466. PMID 28018216 DOI: 10.3389/fphar.2016.00466  0.4
2015 Shah S, Chib R, Raut S, Bermudez J, Sabnis N, Duggal D, Kimball JD, Lacko AG, Gryczynski Z, Gryczynski I. Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent. Journal of Photochemistry and Photobiology. B, Biology. 155: 60-65. PMID 26735001 DOI: 10.1016/j.jphotobiol.2015.12.007  0.4
2015 Lacko AG, Sabnis NA, Nagarajan B, McConathy WJ. HDL as a drug and nucleic acid delivery vehicle. Frontiers in Pharmacology. 6: 247. PMID 26578957 DOI: 10.3389/fphar.2015.00247  0.4
2014 Raut S, Kimball J, Fudala R, Doan H, Maliwal B, Sabnis N, Lacko A, Gryczynski I, Dzyuba SV, Gryczynski Z. A homodimeric BODIPY rotor as a fluorescent viscosity sensor for membrane-mimicking and cellular environments. Physical Chemistry Chemical Physics : Pccp. 16: 27037-42. PMID 25381865 DOI: 10.1039/c4cp04260c  0.4
2014 Basha R, Sabnis N, Heym K, Bowman WP, Lacko AG. Targeted nanoparticles for pediatric leukemia therapy. Frontiers in Oncology. 4: 101. PMID 24860784 DOI: 10.3389/fonc.2014.00101  0.4
2013 Johnson R, Sabnis N, McConathy WJ, Lacko AG. The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer. Pharmaceutics. 5: 353-70. PMID 24244833 DOI: 10.3390/pharmaceutics5020353  0.4
2013 Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Frontiers in Pharmacology. 4: 119. PMID 24093019 DOI: 10.3389/fphar.2013.00119  0.4
2012 Sabnis N, Lacko AG. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics. Therapeutic Delivery. 3: 599-608. PMID 22834404 DOI: 10.4155/tde.12.41  0.4
2012 Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG. Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles International Journal of Nanomedicine. 7: 975-983. PMID 22393294 DOI: 10.2147/IJN.S28029  0.4
2011 McConathy WJ, Paranjape S, Mooberry L, Buttreddy S, Nair M, Lacko AG. Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF). Drug Delivery and Translational Research. 1: 113-20. PMID 25788110 DOI: 10.1007/s13346-010-0012-0  0.4
2011 Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, ... ... Lacko AG, et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia (New York, N.Y.). 13: 309-19. PMID 21472135 DOI: 10.1593/neo.101372  0.4
2010 Sarkar P, Luchowski R, Raut S, Sabnis N, Remaley A, Lacko AG, Thamake S, Gryczynski Z, Gryczynski I. Studies on solvatochromic properties of aminophenylstyryl-quinolinum dye, LDS 798, and its application in studying submicron lipid based structure. Biophysical Chemistry. 153: 61-9. PMID 21041016 DOI: 10.1016/j.bpc.2010.10.005  0.4
2010 Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier. Journal of Drug Targeting. 18: 53-8. PMID 19637935 DOI: 10.3109/10611860903156419  0.4
2008 Sarkar P, Bharill S, Gryczynski I, Gryczynski Z, Nair MP, Lacko AG. Binding of 8-anilino-1-naphthalenesulfonate to lecithin:cholesterol acyltransferase studied by fluorescence techniques. Journal of Photochemistry and Photobiology. B, Biology. 92: 19-23. PMID 18485727 DOI: 10.1016/j.jphotobiol.2008.03.009  0.4
2008 McConathy WJ, Nair MP, Paranjape S, Mooberry L, Lacko AG. Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel. Anti-Cancer Drugs. 19: 183-8. PMID 18176115 DOI: 10.1097/CAD.0b013e3282f1da86  0.4
2007 Lackó AG, Stewart DR, McClain R, Prókai L, McConathy WJ. Recent developments and patenting of lipoprotein based formulations. Recent Patents On Drug Delivery & Formulation. 1: 143-5. PMID 19075881 DOI: 10.2174/187221107780831914  0.4
2007 Lacko AG, Nair M, Prokai L, McConathy WJ. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. Expert Opinion On Drug Delivery. 4: 665-75. PMID 17970668 DOI: 10.1517/17425247.4.6.665  0.4
2007 Singhal SS, Singhal J, Nair MP, Lacko AG, Awasthi YC, Awasthi S. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer. International Journal of Oncology. 30: 717-25. PMID 17273774  0.4
2006 Reshetnyak Y, Tchedre KT, Nair MP, Pritchard PH, Lacko AG. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase. Journal of Biomolecular Structure & Dynamics. 24: 75-82. PMID 16780378 DOI: 10.1080/07391102.2006.10507101  0.4
2006 Lacko AG, Nair M, Paranjape S, Mooberry L, McConathy WJ. Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model. Chemotherapy. 52: 171-3. PMID 16691026 DOI: 10.1159/000093268  0.4
2004 Lane SB, Tchedre KT, Nair MP, Thigpen AE, Lacko AG. Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line. Protein Expression and Purification. 36: 157-64. PMID 15249036 DOI: 10.1016/j.pep.2004.03.009  0.4
2004 Kim H, Jacobson EL, Jacobson MK, Lacko AG, Sirtori CR, Nissen SE. ApoA-1 Milano and Regression of Atherosclerosis [1] (multiple letters) Journal of the American Medical Association. 291: 1319-1320. PMID 15026389  0.4
2002 Lacko AG, Nair M, Paranjape S, Johnso S, McConathy WJ. High density lipoprotein complexes as delivery vehicles for anticancer drugs. Anticancer Research. 22: 2045-9. PMID 12174882  0.4
2001 Murray KR, Nair MP, Ayyobi AF, Hill JS, Pritchard PH, Lacko AG. Probing the 121-136 domain of lecithin:cholesterol acyltransferase using antibodies. Archives of Biochemistry and Biophysics. 385: 267-75. PMID 11368007 DOI: 10.1006/abbi.2000.2154  0.4
2001 Kálmán J, Kudchodkar BJ, Krishnamoorthy R, Dory L, Lacko AG, Agarwal N. High cholesterol diet down regulates the activity of activator protein-1 but not nuclear factor-kappa B in rabbit brain Life Sciences. 68: 1495-1503. PMID 11253166 DOI: 10.1016/S0024-3205(01)00955-9  0.4
2000 Kudchodkar BJ, Lacko AG, Dory L, Fungwe TV. Dietary fat modulates serum paraoxonase 1 activity in rats Journal of Nutrition. 130: 2427-2433. PMID 11015468  0.4
2000 Lacko AG, Barter P, Ehnholm C, Van Tol A. International symposium on basic aspects of HDL metabolism and disease prevention Journal of Lipid Research. 41: 1695-1699. PMID 11013313  0.4
2000 Kalman J, McConathy W, Araoz C, Kasa P, Lacko AG. Apolipoprotein D in the aging brain and in Alzheimer's dementia Neurological Research. 22: 330-336. PMID 10874678  0.4
2000 Ayyobi AF, Lacko AG, Murray K, Nair M, Li M, Molhuizen HOF, Pritchard PH. Biochemical and compositional analyses of recombinant lecithin:cholesterol acyltransferase (LCAT) obtained from a hepatic source Biochimica Et Biophysica Acta - Molecular and Cell Biology of Lipids. 1484: 1-13. PMID 10685026 DOI: 10.1016/S1388-1981(99)00199-7  0.4
1999 Kálmán J, Kudchodkar BJ, Murray K, McConathy WJ, Juhász A, Janka Z, Lacko AG. Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease Dementia and Geriatric Cognitive Disorders. 10: 488-493. PMID 10559565 DOI: 10.1159/000017195  0.4
1999 Murray KR, Nair MP, McConathy WJ, Lacko AG. Enzyme linked immunoassay (ELISA) for lecithin:cholesterol acyltransferase (LCAT) Analytical Letters. 32: 1553-1564.  0.4
1998 Lacko AG, Kudchodkar BJ, Loney WW, Clearfield MB, Weis S. Decrease in high density lipoprotein cholesterol (HDL-C) levels following gemfibrozil therapy. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 36: 389-92. PMID 9711427 DOI: 10.1515/CCLM.1998.066  0.4
1998 Fungwe TV, Kudchodkar BJ, Lacko AG, Dory L. Fatty acids modulate lecithin:cholesterol acyltransferase secretion independently of effects on triglyceride secretion in primary rat hepatocytes Journal of Nutrition. 128: 1270-1275. PMID 9687543  0.4
1998 Lacko AG, Reason AJ, Nuckolls C, Kudchodkar BJ, Nair MP, Sundarrajan G, Pritchard PH, Morris HR, Dell A. Characterization of recombinant human plasma lecithin: cholesterol acyltransferase (LCAT): N-linked carbohydrate structures and catalytic properties. Journal of Lipid Research. 39: 807-20. PMID 9555945  0.4
1998 Nair MP, Haydn Pritchard P, Lacko AG. Lipoprotein substrate binding site of LCAT karen murray Faseb Journal. 12.  0.4
1997 Loney WW, Kudchodkar BJ, Weis S, Clearfield MB, Shores J, Lacko AG. Evaluation of gemfibrozil therapy: predictive response from lipoprotein subfraction analysis. American Journal of Therapeutics. 4: 301-9. PMID 10423623  0.4
1997 Lacko AG, Miller NE. International Symposium on the Role of HDL in Disease Prevention: report on a meeting. Journal of Lipid Research. 38: 1267-73. PMID 9215554  0.4
1997 McConathy W, Lacko A, Kalman J. Senile dementia and apolipoprotein E4 [1] Dementia and Geriatric Cognitive Disorders. 8: 258. PMID 9213073 DOI: 10.1159/000106641  0.4
1997 Nair MP, Kudchodkar BJ, Pritchard PH, Lacko AG. Purification of recombinant lecithin:cholesterol acyltransferase Protein Expression and Purification. 10: 38-41. PMID 9179288 DOI: 10.1006/prep.1996.0711  0.4
1997 Fungwe TV, Kudchodkar BJ, Lacko AG, Dory L. The expression of lecithin:Cholesterol acyltransferase is influenced by diet Faseb Journal. 11.  0.4
1995 Weinberg RB, Jones JB, Haydn Pritchard P, Lacko AG. Effect of interfacial pressure on the binding and phospholipase A2 activity of recombinant human lecithin-cholesterol acyltransferase Biochemical and Biophysical Research Communications. 211: 840-846. PMID 7598713 DOI: 10.1006/bbrc.1995.1888  0.4
1994 Lacko AG, Pritchard PH. 2nd International Symposium on Reverse Cholesterol Transport: Report on a meeting Journal of Lipid Research. 35: 351-356. PMID 8169538  0.4
1994 Knebl J, DeFazio P, Clearfield MB, Little L, McConathy WJ, Mc Pherson R, Lacko AG. Plasma lipids and cholesterol esterification in Alzheimer's disease Mechanisms of Ageing and Development. 73: 69-77. PMID 8028399 DOI: 10.1016/0047-6374(94)90039-6  0.4
1994 Clearfield MB, Lee N, Armstrong L, DeFazio P, Kudchodkar BJ, Lacko AG. The effect of captopril on the oxidation of plasma lipoproteins Pharmacology and Toxicology. 75: 218-221. PMID 7800666  0.4
1994 Lacko AG. The metabolism of high-density lipoproteins Trends in Cardiovascular Medicine. 4: 84-88. DOI: 10.1016/1050-1738(94)90014-0  0.4
1993 Hill JS, O K, Wang X, Paranjape S, Dimitrijevich D, Lacko AG, Pritchard PH. Expression and characterization of recombinant human lecithin:cholesterol acyltransferase. Journal of Lipid Research. 34: 1245-51. PMID 8371071  0.4
1992 Lee Sm, Kudchodkar BJ, Lacko AG. Effect of ethinyl estradiol treatment on lipoproteins and LCAT activity in aged rats Mechanisms of Ageing and Development. 64: 123-131. PMID 1630152 DOI: 10.1016/0047-6374(92)90101-I  0.4
1992 Bleicher JM, Lacko AG. Physiologic role and clinical significance of reverse cholesterol transport Journal of the American Osteopathic Association. 92: 625-632. PMID 1601697  0.4
1992 Lacko AG, Lee SM, Mirshahi I, Hasler-Rapacz J, Kudchodkar BJ. Decreased lecithin: Cholesterol acyltransferase activity in the plasma of hypercholesterolemic pigs Lipids. 27: 266-269. PMID 1518383 DOI: 10.1007/BF02536473  0.4
1992 Weis S, Kudchodkar BJ, Clearfield MB, Lacko AG. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels Artery. 19: 353-367. PMID 1471924  0.4
1991 Lee SM, Kudchodkar BJ, Lacko AG. Age related changes in the lipoprotein substrates for the esterification of plasma cholesterol in rats Mechanisms of Ageing and Development. 61: 85-98. PMID 1779703 DOI: 10.1016/0047-6374(91)90008-N  0.4
1990 Lacko AG, Pritchard PH. International Symposium on Reverse Cholesterol transport. Report on a meeting Journal of Lipid Research. 31: 2295-2299. PMID 1982532  0.4
1989 Sparks DL, Frohlich J, Lacko AG, Pritchard PH. Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients. Atherosclerosis. 77: 183-91. PMID 2751750 DOI: 10.1016/0021-9150(89)90080-4  0.4
1989 Yüksel KU, Park YB, Jung J, Gracy RW, Lacko AG. Studies on the structure of lecithin: Cholesterol acyltransferase (LCAT)-comparisons of the active site region and secondary structure of the human and the porcine enzymes Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 94: 389-394. PMID 2591200 DOI: 10.1016/0305-0491(89)90361-1  0.4
1988 Kudchodkar BJ, Choi Lee MJ, Lee SM, DiMarco NM, Lacko AG. Effect of dietary protein on cholesterol homeostasis in diabetic rats Journal of Lipid Research. 29: 1272-1287. PMID 3235914  0.4
1988 Pritchard PH, McLeod R, Frohlich J, Park MC, Kudchodkar BJ, Lacko AG. Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease) Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 958: 227-234. PMID 3122840 DOI: 10.1016/0005-2760(88)90181-6  0.4
1987 Park YB, Yüksel KU, Gracy RW, Lacko AG. The catalytic center of lecithin: Cholesterol acyltransferase: Isolation and sequence of diisopropyl fluorophosphate-labeled peptides Biochemical and Biophysical Research Communications. 143: 360-363. PMID 3827927 DOI: 10.1016/0006-291X(87)90673-5  0.4
1987 Park MSC, Kudchodkar BJ, Frohlich J, Pritchard H, Lacko AG. Study of the components of reverse cholesterol transport in lecithin: Cholesterol acyltransferase deficiency Archives of Biochemistry and Biophysics. 258: 545-554. PMID 3674887 DOI: 10.1016/0003-9861(87)90376-6  0.4
1986 Carlile SI, Kudchodkar BJ, Wang CS, Lacko AG. Age-related changes in the rate of esterification of plasma cholesterol in Fischer-344 rats. Mechanisms of Ageing and Development. 33: 211-20. PMID 3959602 DOI: 10.1016/0047-6374(86)90028-X  0.4
1986 McLeod R, Lacko AG, Pritchard PH, Frohlich J. Purification of biologically active apolipoproteins by chromatofocussing Journal of Chromatography B: Biomedical Sciences and Applications. 381: 271-283. PMID 3760085 DOI: 10.1016/S0378-4347(00)83593-8  0.4
1986 Park YB, Lacko AG. Isolation and characterization of lecithin-cholesterol acyltransferase from hog plasma Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 877: 179-190. PMID 3718996 DOI: 10.1016/0005-2760(86)90133-5  0.4
1986 Albers JJ, Chen CH, Lacko AG. Isolation, characterization, and assay of lecithin-cholesterol acyltransferase Methods in Enzymology. 763-783. PMID 3014276  0.4
1985 Park YB, Jahani M, Lacko AG. Isolation of high-density lipoproteins by immunoaffinity column chromatography from hog plasma Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 82: 529-533. PMID 4085214 DOI: 10.1016/0305-0491(85)90018-5  0.4
1985 Carlile SI, Lacko AG. Age-related changes in plasma lipid levels and tissue lipoprotein lipase activities of Fischer-344 rats. Archives of Gerontology and Geriatrics. 4: 133-40. PMID 4037932 DOI: 10.1016/0167-4943(85)90027-5  0.4
1985 Koren E, McConathy WJ, Lacko AG, Knowles B. Detection of lecithin: Cholesterol acyltransferase (LCAT) in a human hepatoma cell line Cancer Biochemistry Biophysics. 7: 301-307. PMID 2983879  0.4
1985 Pritchard HP, Mah E, Frohlich J, Lacko AG. Lecithin:cholesterol acyltransferase in Tangier disease Federation Proceedings. 44.  0.4
1984 Lacko AG, Carlile S, Kudchodkar BJ. Evaluation of lipid and lipoprotein metabolism in rats as a model for studying age-related physiological changes. Journal of Gerontology. 39: 513-20. PMID 6470439  0.4
1984 Park MC, McConathy WJ, Lacko AG. Effects of detergents on the lecithin: Cholesterol acyltransferase reaction Archives of Biochemistry and Biophysics. 233: 290-298. PMID 6431910 DOI: 10.1016/0003-9861(84)90628-3  0.4
1984 Carlile SI, Lacko AG. Age related changes in rat lipoprotein metabolism Federation Proceedings. 43: no. 1336.  0.4
1984 Park YB, Lacko AG. Isolation and characterization of lecithin:cholesterol acyltransferase from hog plasma Federation Proceedings. 43.  0.4
1984 Park MC, McConathy WJ, Lacko AG. Effects of detergents on the lecithin:cholesterol acyltransferase (LCAT) reaction Federation Proceedings. 43.  0.4
1983 Chong KS, Hara S, Thompson RE, Lacko AG. Characterization of lecithin:Cholesterol acyltransferase from human plasma. II. Physical properties of the enzyme Archives of Biochemistry and Biophysics. 222: 553-560. PMID 6847201 DOI: 10.1016/0003-9861(83)90553-2  0.4
1983 DeLamatre JG, Hoffmeier CA, Lacko AG, Roheim PS. Distribution of apolipoprotein A-IV between the lipoprotein and the lipoprotein-free fractions of rat plasma: Possible role of lecithin:Cholesterol acyltransferase Journal of Lipid Research. 24: 1578-1585. PMID 6668451  0.4
1983 Chong KS, Jahani M, Hara S, Lacko AG. Characterization of lecithin-cholesterol acyltransferase from human plasma. III. Chemical properties of the enzyme Canadian Journal of Biochemistry and Cell Biology. 61: 875-881. PMID 6627099  0.4
1983 Lacko AG, Hayes JD, McConathy WJ, Lacko I, Redheendran R. Lecithin: cholesterol acyltransferase in Down's syndrome Clinica Chimica Acta. 132: 133-141. PMID 6225568 DOI: 10.1016/0009-8981(83)90241-3  0.4
1982 Jahani M, Lacko AG. Study of the lecithin:Cholesterol acyltransferase reaction with liposome and high density lipoprotein substrates Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 713: 504-511. PMID 6817810 DOI: 10.1016/0005-2760(82)90310-1  0.4
1981 Chong KS, Davidson L, Huttash RG, Lacko AG. Characterization of lecithin:cholesterol acyltransferase from human plasma: Purification of the enzyme Archives of Biochemistry and Biophysics. 211: 119-124. PMID 7305362 DOI: 10.1016/0003-9861(81)90437-9  0.4
1981 Jahani M, Lacko AG. A study of the interaction of lecithin: Cholesterol acyltransferase with subfractions of high density lipoproteins Journal of Lipid Research. 22: 1102-1110. PMID 7299290  0.4
1981 Busbee DL, Payne DM, Jasheway DW, Carlisle S, Lacko AG. Separation and detection of lipoproteins in human serum by use of size-exclusion liquid chromatography: A preliminary report Clinical Chemistry. 27: 2052-2058. PMID 6171365  0.4
1981 Carlile SI, Lacko AG. Strain differences in the age related changes of rat lipoprotein metabolism Comparative Biochemistry and Physiology -- Part B: Biochemistry And. 70: 753-758. DOI: 10.1016/0305-0491(81)90012-2  0.4
1980 Jahani M, Huttash RG, Lacko AG. A Novel Chromatographic Method for the Preparation of High Density Lipoproteins Preparative Biochemistry. 10: 431-444. PMID 6997859 DOI: 10.1080/00327488008061741  0.4
1980 Lacko AG. A test for the biochemical efficiency of isotopic cholesterol Lipids. 15: 983-985. DOI: 10.1007/BF02534428  0.4
1979 Lacko AG, Davis JL. Age-related changes in rat and primate plasma cholesterol metabolism Journal of the American Geriatrics Society. 27: 212-217. PMID 219052 DOI: 10.1111/j.1532-5415.1979.tb06034.x  0.4
1979 Emmett-Oglesby MW, Lacko AG, Harrell E, Jordan J. Cholesterol metabolism in the rat following lesions of the diencephalon Artery. 5: 473-485.  0.4
1978 Lacko AG, Marks AD, Rutenberg HL, Soloff LA. Serum cholesterol esterification in hyperthyroidism and hypothyroidism Hormone and Metabolic Research. 10: 147-151. PMID 649039  0.4
1977 Lacko AG, Rutenberg HL, Soloff LA. The influence of age and sex on the esterification of human serum cholesterol Biochemical Medicine. 17: 275-283. PMID 869939 DOI: 10.1016/0006-2944(77)90033-3  0.4
1977 Lacko AG, F. Chen T. Enzyme purification by affinity chromatography using a non-covalently bound adsorbent Journal of Chromatography A. 130: 446-450. PMID 853092 DOI: 10.1016/S0021-9673(00)89845-3  0.4
1977 Lacko AG. Possible links between plasma cholesterol metabolism and atherosclerosis Journal of the American Osteopathic Association. 76: 470-471.  0.4
1976 Lacko AG. On the interpretation and potential diagnostic value of the measurements related to lecithin:cholesterol acyltransferase activity Clinical Biochemistry. 9: 212-215. PMID 954185 DOI: 10.1016/S0009-9120(76)80060-4  0.4
1976 David JSK, Soloff LA, Lacko AG. Factors affecting the esterification of lipoprotein cholesterol by lecithin: Cholesterol acyl transferase Life Sciences. 18: 701-706. PMID 177834 DOI: 10.1016/0024-3205(76)90181-8  0.4
1975 Britton GW, Rotenberg S, Freeman C, Britton VJ, Karoly K, Ceci L, Klug TL, Lacko AG, Adelman RC. Regulation of corticosterone levels and liver enzyme activity in aging rats. Advances in Experimental Medicine and Biology. 61: 209-228. PMID 241217  0.4
1974 Lacko AG, Rutenberg HL, Soloff LA. Serum cholesterol esterification in species resistant and susceptible to atherosclerosis Atherosclerosis. 19: 297-305. PMID 4813149 DOI: 10.1016/0021-9150(74)90064-1  0.4
1974 Lacko AG, Varma KG, Rutenberg HL, Soloff LA. Studies on enzymatic and molecular properties of lecithin: Cholesterol acyltransferase Scandinavian Journal of Clinical and Laboratory Investigation. 33: 29-34. PMID 4367599 DOI: 10.1080/00365517409100626  0.4
1973 Rutenberg HL, Lacko AG, Soloff LA. Inhibition of lecithin:Cholesterol acyltransferase following intravenous administration of heparin in man Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 326: 419-427. PMID 4776440 DOI: 10.1016/0005-2760(73)90142-2  0.4
1973 Soloff LA, Rutenberg HL, Lacko AG. Serum cholesterol esterification in patients with coronary heart disease. Importance of initial rate of esterification expressed as a function of free cholesterol American Heart Journal. 85: 153-161. PMID 4687117 DOI: 10.1016/0002-8703(73)90455-9  0.4
1973 Lacko AG, Rutenberg HL, Soloff LA. Measurement of the initial rate of serum cholesterol esterification Biochemical Medicine. 7: 178-183. PMID 4684085 DOI: 10.1016/0006-2944(73)90113-0  0.4
1972 Lacko AG, Rutenberg HL, Soloff LA. Recovery of labeled cholesterol and cholesterol esters from thin layer chromatograms Clinica Chimica Acta. 39: 506-510. PMID 5043785 DOI: 10.1016/0009-8981(72)90079-4  0.4
1972 Lacko AG, Rutenberg HL, Soloff LA. On the rate of cholesterol esterification in cord blood serum Lipids. 7: 426-429. PMID 5038495 DOI: 10.1007/BF02531515  0.4
1970 Lacko AG, Neurath H. Studies on procarboxypeptidase A and carboxypeptidase A of the spiny pacific dogfish (squalus acanthias) Biochemistry. 9: 4680-4690. PMID 5529813  0.4
1970 Lacko AG, Brox LW, Gracy RW, Horecker BL. The carboxyl-terminal structure of rabbit liver aldolase (aldolase B) Journal of Biological Chemistry. 245: 2140-2141. PMID 5440846  0.4
1970 Gracy RW, Lacko AG, Brox LW, Adelman RC, Horecker BL. Structural relations in aldolases purified from rat liver and muscle and novikoff hepatoma Archives of Biochemistry and Biophysics. 136: 480-490. PMID 4314111 DOI: 10.1016/0003-9861(70)90219-5  0.4
1969 Gracy RW, Lacko AG, Horecker BL. Subunit structure and chemical properties of rabbit liver aldolase Journal of Biological Chemistry. 244: 3913-3919. PMID 5805405  0.4
1969 Brox LW, Lacko AG, Gracy RW, Adelman RC, Horecker BL. Muscle-type aldolase isolated from a liver tumor Biochemical and Biophysical Research Communications. 36: 994-998. PMID 4310151  0.4
1968 Adelman RC, Lacko AG. The inhibition of bovine pancreatic carboxypeptidase a by dihydroxyacetone phosphate Biochemical and Biophysical Research Communications. 33: 596-601.  0.4
1967 Lacko AG, Neurath H. A monomeric form of procarboxypeptidase A from the spiny pacific dogfish Biochemical and Biophysical Research Communications. 26: 272-277. PMID 6034352  0.4
Show low-probability matches.